Market Synopsis of Lichen Sclerosus Treatment Market
The Lichen Sclerosus Treatment market is projected to reach USD 297.9 Million by 2030 at 9.6% CAGR during the forecast period 2022-2030. Lichen sclerosus is a skin disease that affects the genital and anal areas. In some cases, they may appear on upper body such as arms and breast regions. The main cause of lichen sclerosus is still unknown, but some of the other causes are hormonal imbalance, hyper immunity reactions. 聽Patients with skin destruction around genital or anal region are more susceptible to develop lichen sclerosus. Generally women suffering from vulva鈥檚 lichen sclerosus are at a high risk of developing vulvar cancer.
Increasing prevalence of skin diseases worldwide is one of the major factors contributing to the growth of the market. Moreover, hormonal misbalance in females undergoing menopause are more susceptible to lichen sclerosus, which boosts the growth of market.
On the other hand, availability of exact treatment, and unawareness about rare skin diseases among people may hamper the market growth.
FIGURE 1 Lichen Sclerosus Treatment Global Market by mode of administration, 2016 (%)
Key Players in the Global Lichen Sclerosus Treatment Market 聽
Some of the key players in this lichen sclerosus treatment market are AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Valeant Pharmaceuticals, and Zylera Pharmaceuticals.聽聽
Lichen Sclerosus Treatment Market Segments聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 聽 The global sclerosus treatment market is segmented on the basis of type of treatment, which includes drug therapy and surgery. The drug therapy is further segmented into corticosteroid, immune modulating drugs, retinoid like agents, and others. Surgery is further segmented into laser surgery, circumcision, and others.聽 聽聽
On the basis of mode of administration, the lichen sclerosus treatment market聽is segmented into oral, topical, IV (Intravenous), and others. Oral is further segmented into tablets, capsule, and others. The topical administration is further segmented into creams, ointment, and others.聽
On the basis of end user, the lichen sclerosus treatment market聽is segmented into hospitals, dermatology clinics, pharmacies, and others.
Research Methodology
聽聽
Regional Analysis of the Global Lichen Sclerosus Treatment Market 聽聽
The American region accounted for the largest share of the global lichen sclerosus treatment market due to increasing prevalence of skin disease and demand for new topical products for its treatment. According to the American Osteopathic College of Dermatology, in 2013, USD 75 billion were spent on skin disease by the Americans. Aging population is another factor responsible for the market growth in the American countries.
Europe is the second largest market that holds a noticeable share of the global lichen sclerosus treatment market owing to an increasing awareness regarding skin diseases, demand for skin care cosmetics, and growing market for dermatology in many European countries.
In Asia Pacific, increasing number of dermatology clinics, rising demand for evidence based skin care, and increasing prevalence of skin diseases drives the growth of the lichen sclerosus treatment market.
The Middle East & Africa is expected to show a steady but positive growth in this market due constant demand for diagnostics services in dermatology.
The report on the global lichen sclerosus treatment market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions聽
Intended Audience
- Medical Device Manufacturers
- Medical Research Laboratories
- Research and Development (R&D) Companies
- Market Research and Consulting Service Providers
- Potential Investors
Report Attribute/Metric
|
Details
|
聽聽Market Size
|
聽聽USD 297.9 Million
|
聽聽CAGR
|
聽聽9.6%
|
聽聽Base Year
|
聽聽2021
|
聽聽Forecast Period
|
聽聽2022-2030
|
聽聽Historical Data
|
聽聽2020
|
聽聽Forecast Units
|
聽聽Value (USD Million)
|
聽聽Report Coverage
|
聽聽Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
|
聽聽Segments Covered
|
路聽 Type Of Treatment
路聽 Mode Of Administration
路聽 End Users
|
聽聽Geographies Covered
|
聽聽North America, Europe, Asia-Pacific, and Rest of the World (RoW)
|
聽聽Key Vendors
|
聽聽AstraZeneca plc, Bristol-Myers Squibb Company, GlaxoSmithKline plc, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Sandoz AG (Novartis AG), Sanofi S.A., Valeant Pharmaceuticals, and Zylera Pharmaceuticals.
|
聽聽Key Market Opportunities
|
路聽 New topical products
路聽 Skin care cosmetics
路聽 Dermatology
|
聽聽Key Market Drivers
|
路聽 Increasing prevalence of skin diseases worldwide
路聽 Hormonal misbalance in females undergoing menopause
|
Lichen Sclerosus Treatment Market Highlights:
Frequently Asked Questions (FAQ) :
Lichen Sclerosus Treatment Market is projected to grow at approximately 7.8% CAGR during the assessment period (2017-2023).
Lichen Sclerosus Treatment Market is estimated to reach a valuation of approx. USD 297.9 Million by the end of 2030.
Increasing prevalence of skin diseases and the rising per capita healthcare expenditure, are major tailwinds pushing the growth of the global Lichen Sclerosus Treatment Market.
North America holds the largest share in the Global Lichen Sclerosus Treatment Market, followed by Europe and the Asia Pacific, respectively.
AstraZeneca plc., GlaxoSmithKline plc., Bristol-Myers Squibb Company, Johnson & Johnson Services, Inc., Pfizer Inc., Merck & Co., Inc., Sandoz AG (Novartis AG), Valeant Pharmaceuticals, Sanofi S.A., and Zylera Pharmaceuticals, are some of the top players operating in the Global Lichen Sclerosus Treatment Market.